Health Care & Life Sciences » Healthcare Provision | Thyrocare Technologies Ltd.

Thyrocare Technologies Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,463
1,746
2,312
3,044
3,563
Cost of Goods Sold (COGS) incl. D&A
720
1,009
1,324
1,570
1,766
Gross Income
743
737
988
1,474
1,798
SG&A Expense
147
198
275
441
504
EBIT
588
517
693
-
1,280
Unusual Expense
-
4
32
271
7
Non Operating Income/Expense
96
152
162
88
164
Interest Expense
2
3
6
2
3
Pretax Income
689
665
818
817
1,450
Income Tax
227
231
300
388
517
Consolidated Net Income
462
435
518
428
933
Net Income
462
447
518
428
933
Net Income After Extraordinaries
462
447
518
428
933
Net Income Available to Common
462
447
518
428
933
EPS (Basic)
8.59
8.31
10.06
8.00
17.36
Basic Shares Outstanding
54
54
51
54
54
EPS (Diluted)
8.59
8.31
10.06
7.98
17.32
Diluted Shares Outstanding
54
54
52
54
54
EBITDA
651
645
875
1,179
1,481
Other Operating Expense
9
22
20
35
13
Non-Operating Interest Income
-
7
3
2
2
Minority Interest Expense
-
12
-
-
-

About Thyrocare Technologies

View Profile
Address
MIDC Turbhe
Navi Mumbai Maharashtra 400703
India
Employees -
Website http://www.thyrocare.com
Updated 09/14/2018
Thyrocare Technologies Ltd. engages in provison of indepedent diagnostic and pathological laboratory services. It operates through the following segments: Diagnostic Testing Services, Imaging Services and Others. The Imaging Services segment represents PET-CT scan and sale of radio pharmaceuticals used in imaging services.